Rivaroxaban [rivaroxaban]
topical
261
- Terms
-
Xarelto
-
5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide
BAY 59-7939
Xarelto
Persistent link
https://www.medvik.cz/link/D000069552
Definition
A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME.
- DUI
- D000069552 MeSH Browser
- CUI
- M0501463
- History note
- 2016 (2005)
- Public note
- 2016; RIVAROXABAN was indexed under MORPHOLINES and THIOPHENES 2005-2015
Allowable subheadings
- AD
- administration & dosage 74
- AE
- adverse effects 58
- AG
- agonists
- AA
- analogs & derivatives 1
- AN
- analysis 1
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 2
- PK
- pharmacokinetics 20
- PD
- pharmacology 46
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 125
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D02.886.778.440
Morantel
D02.886.778.840
Ticrynafen
D03.383.533.640.250
Dextromoramide
D03.383.533.640.950
Xamoterol
D03.383.903.440
Morantel
D03.383.903.840
Ticrynafen